Department of Nephrology, National Center for Global Health and Medicine, Tokyo, Japan.
Department of Rehabilitation, National Center for Global Health and Medicine, Tokyo, Japan.
Birth Defects Res. 2019 Dec 1;111(20):1633-1642. doi: 10.1002/bdr2.1558. Epub 2019 Jul 24.
Clinical studies on the effects of thalidomide-induced damage on thalidomide victims as they age have only recently started to be conducted, but no studies have examined socioeconomic differences in terms of healthcare and social status between thalidomiders and the age-matched general population in Japan. Therefore, we carried out a nationwide survey focusing on the life situations of thalidomiders.
Questionnaires were sent to 274 thalidomiders in Japan. The questionnaire items basically matched those of the Comprehensive Survey of Living Conditions (CSLC) in the general population conducted by the Japanese Government. The results were compared with those of the CSLC for individuals aged 55-59 years, which was the cohort most similar in age to the average thalidomider living in Japan.
More thalidomiders rated their health condition as relatively bad or bad compared with the general population (20.2% vs. 13.3%, respectively). A much higher percentage of thalidomiders reported having some health or physical problem caused by a disease or injury (68.8% vs. 32.6%, respectively), and thalidomiders reported visiting medical and healthcare-related facilities more frequently. A higher proportion of thalidomiders (9.2%) were unemployed, and thalidomiders tended to feel higher levels of worry and stress, especially in terms of the future.
The results of this nationwide survey of the life situations of thalidomiders in Japan clarified their health conditions and the related associations with socioeconomic status. These findings could be expected to help improve the provision of medical and healthcare, welfare measures, and financial support for thalidomiders in the near future.
关于沙利度胺引起的损害对衰老的沙利度胺受害者的影响的临床研究最近才开始进行,但没有研究考察过日本沙利度胺患者和同龄普通人群在医疗保健和社会地位方面的社会经济差异。因此,我们进行了一项全国性调查,重点关注沙利度胺患者的生活状况。
向日本的 274 名沙利度胺患者发送了问卷。问卷项目基本与日本政府进行的普通人群综合生活状况调查(CSLC)的项目相匹配。将结果与 CSLC 中年龄最接近的日本平均沙利度胺患者的 55-59 岁年龄组的结果进行比较。
与普通人群相比,更多的沙利度胺患者认为自己的健康状况相对较差或较差(分别为 20.2%和 13.3%)。沙利度胺患者报告有更多因疾病或伤害而导致的某种健康或身体问题的比例(分别为 68.8%和 32.6%),并且沙利度胺患者更频繁地去医疗和保健相关设施就诊。更多的沙利度胺患者(9.2%)失业,沙利度胺患者感到更多的担忧和压力,尤其是对未来。
这项对日本沙利度胺患者生活状况的全国性调查结果阐明了他们的健康状况及其与社会经济地位的相关关联。这些发现有望在不久的将来帮助改善对沙利度胺患者的医疗保健、福利措施和财政支持。